[Tetracyclines for the treatment of mycoplamic prostato-urethritis].
D000328:Adult; D004305:Dose-Response Relationship, Drug; D004318:Doxycycline / Q000378:metabolism / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D008911:Minocycline / Q000378:metabolism / Q000494:pharmacology; D009174:Mycoplasma / Q000187:drug effects; D009175:Mycoplasma Infections / Q000188:drug therapy*; D010118:Oxytetracycline / Q000378:metabolism / Q000494:pharmacology; D011472:Prostatitis / Q000188:drug therapy*; D013754:Tetracyclines / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D014509:Ureaplasma / Q000187:drug effects; D014526:Urethritis / Q000188:drug therapy*
D013754:Tetracyclines; D008911:Minocycline; D004318:Doxycycline; D010118:Oxytetracycline
Tetrazykline zur Behandlung der Mykoplasmen-Prostato-Urethritis